Taylor Devlin | Revenue Accountant |
Phillip Chan | Chief Executive Officer |
Kathleen Bloch | Interim Chief Financial Officer |
Efthymios Deliargyris | Chief Medical Officer |
Christian Steiner | Executive Vice President of Sales and Marketing |
Thomas Kerr | Zacks Investment Research |
Sean Lee | H.C. Wainwright & Co. |
Good afternoon and welcome to the Cytosorbents First Quarter 2023 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company's request.
At this time, I'd like to turn the call over to our moderator, Taylor Devlin.